title: Pretransplant MELD score as a predictor of outcome after liver transplantation for chronic hepatitis C.
abstract: The Model of End-Stage Liver Disease (MELD) score, an accurate predictor of mortality in patients awaiting liver transplantation (OLTX), did not predict graft or patient survival in the post-transplant setting. Our aim was to test the model in patients who underwent OLTX for chronic hepatitis C. Two hundred and eighty-seven adult patients who underwent primary OLTX for chronic hepatitis C between December 1993 and September 1999 were studied from a prospectively maintained database. The group was stratified by MELD scores of less than 15, 15-24, and greater than 24. Patient survival, graft survival, and interval liver biopsy pathology were reviewed. Both patient and graft survival at 3, 6, and 12 months were significantly lower in the higher MELD score groups, as was patient survival at 24 months (p-values, 0.01-0.05). The difference in survival between the low, medium, and high MELD score groups increases in time. The survival without bridging fibrosis in the allograft at 1 year post-transplant was significantly lower with higher MELD scores (p = 0.037). The decrease in survival seen in hepatitis C patients with MELD scores greater than 24 raises questions of transplant suitability for these patients. Therapeutic modalities to decrease post-transplant graft injury in these patients should be explored.
authors.affiliation: Transplantation Services, Baylor University Medical Center, Dallas, TX, USA.
authors.forename: Nicholas N
authors.initials: NN
authors.lastname: Onaca
authors.forename: Marlon F
authors.initials: MF
authors.lastname: Levy
authors.forename: George J
authors.initials: GJ
authors.lastname: Netto
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Thomas
authors.forename: Edmund Q
authors.initials: EQ
authors.lastname: Sanchez
authors.forename: Srinath
authors.initials: S
authors.lastname: Chinnakotla
authors.forename: Carlos G
authors.initials: CG
authors.lastname: Fasola
authors.forename: Jeffrey S
authors.initials: JS
authors.lastname: Weinstein
authors.forename: Natalie
authors.initials: N
authors.lastname: Murray
authors.forename: Robert M
authors.initials: RM
authors.lastname: Goldstein
authors.forename: Goran B
authors.initials: GB
authors.lastname: Klintmalm
mesh_terms: D000328:Adult; D000368:Aged; D019992:Databases as Topic; D005260:Female; D006085:Graft Survival; D019698:Hepatitis C, Chronic / Q000401:mortality / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016031:Liver Transplantation / Q000379:methods*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D018805:Sepsis; D013997:Time Factors; D016896:Treatment Outcome; D014850:Waiting Lists
chemical_list: D007166:Immunosuppressive Agents